BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30878354)

  • 1. Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: A 5-year prospective study.
    Ma G; Wang Y; Hou D; Liu J; Zhang J; Xu L; Wang H; Zhao W; Zhang Y; Zhang L
    J Cardiol; 2019 Sep; 74(3):251-257. PubMed ID: 30878354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment.
    Ma G; Chen L; Yue Y; Liu X; Wang Y; Shi C; Song F; Shi W; Lo Y; Zhang L
    BMC Cardiovasc Disord; 2021 Dec; 21(1):619. PubMed ID: 34963460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy.
    Haghikia A; Kaya Z; Schwab J; Westenfeld R; Ehlermann P; Bachelier K; Oettl R; von Kaisenberg CS; Katus HA; Bauersachs J; Hilfiker-Kleiner D
    Basic Res Cardiol; 2015 Nov; 110(6):60. PubMed ID: 26519371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors.
    Liu J; Wang Y; Chen M; Zhao W; Wang X; Wang H; Zhang Z; Zhang J; Xu L; Chen J; Yang X; Zhang L
    PLoS One; 2014; 9(1):e86770. PubMed ID: 24466231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy.
    Warraich RS; Sliwa K; Damasceno A; Carraway R; Sundrom B; Arif G; Essop R; Ansari A; Fett J; Yacoub M
    Am Heart J; 2005 Aug; 150(2):263-9. PubMed ID: 16086928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Autoantibody against M2-Muscarinic Acetylcholine Receptor in Heart Failure Patients on Digoxin Treatment.
    Hou D; Fan Z; Xu L; Wang H; Zhang Z; Ma G; Xu X; Wang X; Zhang J; Liu J; Zhang L
    Cardiology; 2018; 141(1):9-17. PubMed ID: 30293082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of programmed cell death-1 and its ligand B7 homolog 1 in peripheral blood lymphocytes from patients with peripartum cardiomyopathy.
    Xia G; Zheng X; Yao X; Yao X; Liu Z; Wang J
    Clin Cardiol; 2017 May; 40(5):307-313. PubMed ID: 28026044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience.
    Bouabdallaoui N; Demondion P; Maréchaux S; Varnous S; Lebreton G; Mouquet F; Leprince P
    Arq Bras Cardiol; 2018 Feb; 110(2):181-187. PubMed ID: 29466490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort.
    Nabbaale J; Okello E; Kibirige D; Ssekitoleko I; Isanga J; Karungi P; Sebatta E; Zhu ZW; Nakimuli A; Omagino J; Kayima J
    PLoS One; 2020; 15(10):e0240837. PubMed ID: 33085703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy.
    Ntusi NB; Badri M; Gumedze F; Sliwa K; Mayosi BM
    PLoS One; 2015; 10(8):e0133466. PubMed ID: 26252951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients.
    Goland S; Weinstein JM; Zalik A; Kuperstein R; Zilberman L; Shimoni S; Arad M; Ben Gal T; George J
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.
    McTiernan CF; Morel P; Cooper LT; Rajagopalan N; Thohan V; Zucker M; Boehmer J; Bozkurt B; Mather P; Thornton J; Ghali JK; Hanley-Yanez K; Fett J; Halder I; McNamara DM;
    J Card Fail; 2018 Jan; 24(1):33-42. PubMed ID: 29079307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison and analysis of different diagnostic criteria for peripartum cardiomyopathy].
    Wang Y; Gao Z; Liu GL; Wei J; Zhang XH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):487-91. PubMed ID: 22041438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.
    Ersbøll AS; Bojer AS; Hauge MG; Johansen M; Damm P; Gustafsson F; Vejlstrup NG
    J Am Heart Assoc; 2018 Oct; 7(20):e008991. PubMed ID: 30371259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
    Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
    Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
    Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
    Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
    Sliwa K; Hilfiker-Kleiner D; Mebazaa A; Petrie MC; Maggioni AP; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; van Veldhuisen DJ; Roos-Hesslink JW; Shah AJ; Seferovic PM; Elkayam U; van Spaendonck-Zwarts K; Bachelier-Walenta K; Mouquet F; Kraigher-Krainer E; Hall R; Ponikowski P; McMurray JJ; Pieske B
    Eur J Heart Fail; 2014 May; 16(5):583-91. PubMed ID: 24591060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
    Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripartum Serial Echocardiographic Findings in a Patient with Life-threatening Peripartum Cardiomyopathy.
    Aoyama D; Hamatani Y; Kamiya C; Ohta-Ogo K; Amaki M; Kawakami S; Okada A; Takahama H; Hasegawa T; Sugano Y; Kanzaki H; Ishibashi-Ueda H; Yasuda S; Anzai T
    Intern Med; 2018 Nov; 57(21):3105-3109. PubMed ID: 29877258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.